Beta blockers may lead to new novel triple negative breast cancer treatments

New research shows that a commonly prescribed class of high blood pressure drugs may have the potential to slow the growth of triple negative breast cancer tumors. These drugs, called ‚beta blockers‘ work by counteracting the pro-growth effect caused by adrenaline by affecting the the beta2-adrenoceptor. (Mehr in: Cancer News — ScienceDaily)